 |
WallSt.net Interviews Urigen Pharmaceuticals' CEO, Bill Garner (PDF, )
Monday August 13 2007 |
|
|
Urigen Pharmaceuticals Completes $2.1 Million Financing (PDF, )
Monday August 6 2007 |
|
|
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. Announces Name Change and New Stock Symbol (PDF, )
Thursday July 30 2007 |
|
|
Urigen N.A., Inc. Completes Reverse Merger With Valentis, Inc. (PDF, 103kb)
Monday July 16 2007, 8:37am EST |
|
|
Urigen N.A., Inc. Completes Shareholder Meeting (PDF, 55kb)
Monday June 29 2007, 8:44am EST |
|
|
Urigen N.A. Inc. Board Member Resigns (PDF, 27kb)
Monday June 18 2007, 5:45pm EST |
|
|
Urigen N.A. and S. Grant Mulholland, M.D. to Collaborate on URG301 Drug Development Project for Overactive Bladder (PDF, 23kb)
Tuesday June 13 2007, 1:04pm EST |
|
|
Valentis, Inc. and Urigen N.A., Inc. Announce the Filing of a Registration Statement Relating to Their Proposed Merger Transaction (PDF, 78kb)
Monday February 7 2007, 2:05pm EST |
|
|
Urigen N.A., Inc. Appoints Dennis Giesing, PhD As Director of Product Development (PDF, 75kb)
Monday January 8 2007, 9:04am EST |
|
|
Urigen N.A., Inc. Engages Sichenzia Ross Friedman Ference LLP (PDF, 74kb)
Thursday December 21 2006, 12:57pm EST |
|
|
Urigen N.A., Inc. Appoints Terry M. Nida to Chief Operating Officer (PDF, 75kb)
Wednesday November 29 2006, 8:30am |
|
|
Urigen N.A. Announces Phase 2 Results for U101 in Chronic Pelvic Pain (PDF, 77kb)
Monday October 30 2006, 4:15pm |
|
|
Urigen N.A., Inc. Retains The Investor Relations Group of New York (PDF, 72kb)
Monday October 30 2006, 2:30pm |
|
|
|
